生命科学资讯

In the clinic for Dec. 1, 2025

Other news to note for Dec. 1, 2025

Regulatory actions for Dec. 1, 2025

Regeneron inks gene editing deal with startup Tessera

Microsize, Schedio link to buy Lonza’s Swiss micronization plant - Fierce Pharma

Study Compares Performance of Emerging Droplet-Based scRNA-seq Platforms to 10x Genomics System - geneonline.com

UK to spend more on medicines for US tariff exemption

Inspecting Bulk Peanuts - AZoM

Belite brings FDA filing into view with phase 3 Stargardt disease victory

GE HealthCare, Philips, Siemens spotlight AI-forward imaging at RSNA 2025

Researchers find chronic stress you can see using a CT scan

Akebia to pay $12M to Q32 Bio for centerpiece of rare kidney disease pipeline

Angelini, European Investment Bank join forces; Radiopharma startup raises $40M

Comparative Study of Two Innovative Single-Cell RNA Platforms - Bioengineer.org

Rothschild & Co Redburn Adjusts Price Target on Agilent Technologies to $180 From $165, Maintains Buy Rating - MarketScreener

Med-tech gainers and losers for Nov. 24-26, 2025

Pittsburgh Playhouse, Thermo Fisher Scientific, East End Food Co-op and more: Pittsburgh jobs for 12/1/25 - NEXTpittsburgh

Lilly slightly lowers self-pay prices for single-dose vials of Zepbound

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight - WebWire

Agilent (A) International Revenue Performance Explored - Yahoo Finance